children with limb fracture
Conditions
Interventions
Esketamine combined with sufentanil group:Esketamine combined with sufentanil for patient-controlled intravenous analgesia pump
Sufentanil group:Sufentanil for patient-controlled intravenous analgesia pump
Sponsors
The First People's Hospital of Lianyungang
Eligibility
Sex/Gender
All
Age
2 Years to 7 Years
Inclusion criteria
Inclusion criteria: 1. Aged 2-7 years; 2. New cases of traumatic fracture; 3. ASA grading ?-?; 4. Obtain the informed consent of the guardian of the child; 5. BMI 13-20 kg/m^2.
Exclusion criteria
Exclusion criteria: 1. Severe congenital disease or congenital disease that researchers believe will affect the results of the experiment; 2. Patients with history of bronchial asthma; 3. Abnormal heart, lung, liver and kidney function; 4. Patients who are allergic to the drug ingredients in this study; 5. Patients with mental and cognitive disorders that researchers believe may have influenced the experimental results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FLACC analgesia score at 48 hours after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ramsay sedation score at 48 hours postoperatively;PCA sufentanil usage at 48 hours postoperatively;Number of effective PCA compressions at 48 hours postoperatively;Parental satisfaction with pain control;Incidence of adverse reactions; | — |
Countries
China
Contacts
Public ContactChen Ying
The First People's Hospital of Lianyungang
Outcome results
None listed